YuanBio Venture Capital

Partner with over 20 years in pharmaceutical R&D, manufacturing and investment; previously Chairman of Sunforest Capital, Managing Partner at Yuanming Capital, and a scientist at Eisai and Wyeth. Holds an MBA from Babson and degrees in chemistry and pharmaceutical sciences.

Partner with over 10 years in biopharma R&D and investment; rose from Analyst to VP at YuanBio Venture Capital and previously a medicinal chemistry researcher at Basilea Pharmaceutica. Holds degrees from the Shanghai Institute of Organic Chemistry and China Pharmaceutical University.

Partner with over 15 years in biomedical research and precision medicine; previously Chief Scientific Officer at Novogene and held oncology roles at Roche/Genentech and BeiGene. Holds a PhD from Rice University and completed postdoctoral work at Harvard Medical School.

Partner with over 20 years in medical device marketing, manufacturing, R&D and sales; held leadership roles at Johnson & Johnson, Philips Home Healthcare, Biosensor International, JW Medical Systems and others. Holds medical degrees from Shanghai Jiao Tong University and Fudan University.

Partner with over 20 years in finance, law and investment, including law practice serving CDB and Xinda Asset Management; previously Managing Director at Eastern Link Capital and Executive Director at CXC Capital. Holds an EMBA from CEIBS and an LLM from Peking University.

Managing Partner with extensive experience in medicine and medical device investing; previously Executive Director at Riverhead Capital, Managing Director at Korean Investment Partners, and co-founder of Eastwin Life Sciences. Holds an MBA from University of Chicago, a PhD in molecular biology from Columbia, and a biology degree from Peking University.

Managing Director focused on digital health, AI and consumer health; previously Executive Director at Taikang Healthcare Fund and Associate Director at Monitor Deloitte. Holds master's degrees from Georgia Tech and a bachelor's from Peking University.